$KEYS

Morgan Stanley Says This AI Pick and Shovel Stock Has 25% Upside

Morgan Stanley upgraded Keysight Technologies (NYSE: KEYS) to Overweight from Equal Weight and raised its price target to $400 from $350. The target implies about 25% upside versus a $319 share price. The firm cites Keysight as an AI “pick-and-shovel” for testing at higher networking speeds and notes strong AI-related revenue growth.

Original reporting
Published Jul 13, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 13, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley Says This AI Pick and Shovel Stock Has 25% Upside — source image
Decision brief

The 30-second read

$KEYSBullishMed
01

Why it matters

The key new information is the Morgan Stanley rating upgrade and raised price target, with a thesis tied to AI investment and broader architectures rather than specific chip winners.

02

Market read

Traders can use the upgrade and target raise as a catalyst for short-term positioning, while monitoring whether AI-related testing demand sustains beyond sentiment.

03

What to watch

Valuation risk is highlighted in the article, including consensus revenue CAGR assumptions that may not justify the current price if AI-related demand normalizes.

Relevance 7/10Novelty 7/10Timing: after-hours/overnight analyst upgrade and price-target raise

Background

The piece frames Keysight as a “pick-and-shovel” supplier for validating next-generation networking speeds used in AI data centers.

Company-level read

Ticker impact

$KEYSBullishMedium confidence
Context

Morgan Stanley upgraded Keysight Technologies to Overweight and raised its price target to $400 from $350, citing AI-driven testing demand.

Expected impact

Likely modest positive drift as traders price in the upgrade, with upside capped if the AI hype premium fades.

Evidence & confidence

The article’s actionable catalyst is the fresh upgrade and explicit target change, but it does not include new company fundamentals like earnings or guidance.

Market effects

Supports the view that electronic design automation and test/measurement vendors can benefit from faster AI networking roadmaps (800G, 1.6T, 3.2T).

Primarily US large-cap semiconductor/industrial tech sentiment; limited direct regional spillover beyond US-listed peers.

Reinforces global AI infrastructure capex read-through for equipment used by chipmakers and network equipment manufacturers.

Counterpoint

The bullish case may be overstating fundamentals if the stock’s move is driven by an AI multiple expansion rather than durable order growth.

Key entities

  • Keysight Technologies

    Electronic design and test solutions provider; subject of the Morgan Stanley upgrade and price-target increase.

  • Morgan Stanley

    Brokerage that upgraded KEYS to Overweight and raised its price target.

Related articles

$KEYSMed

Keysight's RFPro Software Certified for Intel's 14A and 18A-P Process Technologies

Keysight Technologies said its RFPro electromagnetic design software has been certified for Intel Foundry’s 14A and 18A-P process technologies, allowing chip designers to simulate performance before manufacturing. The company said this builds on existing support for Intel’s 18A and EMIB-T packaging. The article notes KEYS shares fell about 3.6% to $307.25 and Intel about 3.1% to $89.47.

$KEYSMed

Keysight Technologies, Inc.: Keysight and Sateliot Selected by European Space Agency to Develop Blockchain-Enabled Framework for 5G Non-Terrestrial Networks

Keysight Technologies (NYSE: KEYS) was selected by the European Space Agency to lead a three-year ESA ARTES program developing a blockchain-enabled, secure anomaly detection framework for 5G non-terrestrial networks. Keysight will work with Sateliot on technical development and satellite mission integration, aiming to support trusted NTN operations and future 6G/AI network assurance.

$AXPMed

American Express, Biogen upgraded: Wall Street's top analyst calls

Wall Street analysts issued multiple rating changes. JPMorgan raised American Express (AXP) to Overweight, PT $400. Truist upgraded Biogen (BIIB) to Buy, PT $235, citing upcoming Phase 2 and Phase 3 readouts. JPMorgan also raised Keysight (KEYS) to Overweight, PT $400. Other actions included upgrades for Humana (HUM) and downgrades for Papa John’s (PZZA) and Best Buy (BBY).

$KEYSMedAI 8/10

Cybeats Technologies Corp.: Cybeats Technologies Corp. Announces First Quarter Fiscal 2026 Financial Results

Cybeats Technologies Corp. reported Q1 fiscal 2026 results for the three months ended March 31, 2026. Revenue rose to $763,679 from $681,128 (+12%). Net loss widened to $2,430,993 from $1,185,102, with cash expenses down ~15% to $1,620,766. Cash fell to $1,072,900 from $2,751,202. The company also cited a Keysight OEM partnership and an automotive contract, and said it aims to reach ~$5M ARR by end of Q2 2026.

$KEYSLow

Keysight Tackles Semiconductor Talent Gap with Executable RF Design Whiteboard

Keysight Technologies said its RF Circuit Simulation Professional software now includes an “executable whiteboard” that captures an engineer’s RF design workflow—simulations, optimizations, decision trees, and parameters—into editable Python code. Keysight says the code can be saved, shared, and reused across Keysight ADS, Cadence Virtuoso, and Synopsys Custom Compiler. The company cited McKinsey’s estimate of an 88,000-engineer semiconductor gap by 2029.

$KEYSHighAI 9/10

Keysight’s Q1 Earnings Call: Our Top 5 Analyst Questions

Keysight reported Q1 CY2026 revenue of $1.72B (vs $1.70B est) and adjusted EPS of $2.87 (vs $2.32 est), with adjusted EBITDA of $608.7M. Management attributed results to AI data center infrastructure growth, commercial communications strength, and momentum in aerospace/defense/semiconductors. Q2 guidance calls for $1.74B revenue and $2.46 adjusted EPS at the midpoint, both above estimates.